The Cytocast vision is to change personalized medicine. Make it fully predictable by the most detailed model of a cell.
Cytocast started a long path from an early scientific idea to reach the goal of an automatized treatment suggestion system.
February 2023
Cytocast gains regulatory approval for informing treatment decisions in patients with Fibrosis
February 2022
Cytocast can simulate drugs acting on surface protein receptors
February 2021
Cytocast can simulate the transcriptional modification caused by drug administration.
January 2021
Drug development companies can use Cytocast Whole Cell Simulator to accelerate drug development.
February 2020
Covid-19 didn’t stop us! We fight to stop COVID: we use Cytocast to find treatments against lung fibrosis, which causes some of the complications for patients.
